Moreover, IGF-1 treatment obviously rescued the inhibition of cell proliferation and migration caused by ARHGAP10 overexpression in NSCLC cells (Fig. 5c, d). The gene discussed is ARHGAP10; the disease is non-small cell lung carcinoma.